# A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)

> **NCT00519714** · PHASE2,PHASE3 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 195 (estimated)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DIETARY_SUPPLEMENT:** 1-Methylnicotinamide (1-MNA)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00519714
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 195 (ESTIMATED)
- **Last updated:** 2020-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519714, "A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00519714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*